Intestinal Pathogen B. Fragilis Found to Reprogram Host Metabolism Creating Oxygen-Rich Environments for Cancer Growth

A new study in Cell shows how the ETBF pathogen reshapes host metabolism to fuel its own growth and trigger cancer. Discover the link between microbes and oxygen.

By: AXL Media

Published: May 1, 2026, 6:20 AM EDT

Source: Information for this report was sourced from Vanderbilt University Medical Center

Microbial Subversion of Intestinal Homeostasis Through Toxic Reprogramming

A multi-institutional research team led by Vanderbilt University Medical Center has identified a sophisticated mechanism by which the pathogen enterotoxigenic Bacteroides fragilis, or ETBF, dominates the competitive gut environment. Published in the journal Cell, the findings indicate that this microbe does not merely survive inflammation but actively orchestrates it by producing a toxin that interacts with intestinal epithelial cells. This toxin initiates a metabolic shift within the host, fundamentally altering the resources available in the large intestine. By hijacking the host's cellular machinery, the pathogen ensures its own proliferation while simultaneously driving the progression of inflammatory conditions and colorectal cancer.

Challenging the Anaerobic Paradox in Oxygenated Gut Environments

Traditionally, ETBF has been classified as a classical anaerobe, a type of bacteria that typically thrives only in low oxygen conditions. However, the study led by Dr. Wenhan Zhu discovered that ETBF toxin reduces the oxygen consumption of host cells, which paradoxically increases the amount of oxygen available in the intestinal lumen. While oxygen and oxidative stress are usually toxic to anaerobes, the researchers observed that ETBF successfully navigates and exploits these conditions to gain a competitive advantage over other microbes. This discovery challenges long standing biological assumptions about microbial tolerance and suggests that pathogens can thrive in environments previously thought to be inhospitable.

Strategic Modification of the Intestinal Landscape to Fuel Disease

The research demonstrated that the metabolic reprogramming triggered by ETBF creates a "disease promoting niche" that facilitates the growth of microbial communities associated with colorectal cancer. Beyond altering oxygen levels, the pathogen manipulates immune signaling pathways and bile acid biology to further destabilize the gut. The study found that ETBF also drives epithelial cell proliferation, a hallmark of early stage cancer development. By systematically reshaping the intestinal landscape, the microbe ensures a steady supply of nutrients and resources, effectively transforming the host's gut into a specialized incubator for its own growth and long term pathology.